STERIALS

A clinical-stage pharmaceutical company engaged in the development of therapeutics based on cannabinoid therapy. The company is developing treatments for Tourette's syndrome, obstructive sleep apnea syndrome, Alzheimer's disease, autism spectrum disorder, pain, and is also working on commercializing an oral formulation of palmitoylethanolamide (PEA) for the relief of chronic pain and inflammation.